Inhibition of the serine/threonine kinase BUB1 reverses taxane resistance in prostate cancer
M. J. Martinez, R. D. Z. Lyles, N. Peinetti, A. M. Grunfeld, K. L. Burnstein
This study shows that inhibiting BUB1 kinase reverses taxane resistance in prostate cancer by re-sensitizing resistant cells to docetaxel and cabazitaxel.
bioRxiv · May 5, 2023 · PreprintCancer Biology